& Salakhutdinov, R
Study Characteristics The 15 included trials were conducted across Italy (n=9), the United States (n=3), Russia (n=1), Iran (n=1), and India (n=1), and were published between 1983 and 2024
TABLE 1 Comparative summary of lipid-based nanoparticles and their key characteristics
It is indicated in the treatment of systemic primary carnitine deficiency,It is used in the treatment of Cardiomyopathy (weak heart muscles), skeletal myopathy (weak skeletal muscles), Ischaemic cardiomyopathy (Coronary heart disease), long term haemodialysis, Oligospermia (low sperm count).It is also given along with Valproate therapy
GBB is also one of the most reliably thermogenic compounds available in supplements the mechanism involves activation of carnitine biosynthesis pathways that have downstream effects on beta-oxidation and body temperature regulation
Investigation of lipid metabolismassociated pathways in cellular and biochemical models